
May 7 (Reuters) - LivaNova PLC LIVN.O:
LIVANOVA ANNOUNCES 12-MONTH DATA FROM OSPREY CLINICAL STUDY FOR MODERATE TO SEVERE OBSTRUCTIVE SLEEP APNEA, DEMONSTRATING STRONG RESPONSE AND DURABILITY OF THERAPY
LIVANOVA : OVERALL RESPONDER RATE OF 65% , OVERALL REDUCTION IN MEDIAN APNEA-HYPOPNEA INDEX OF 68%
LIVANOVA : OVERALL REDUCTION IN MEDIAN OXYGEN DESATURATION INDEX OF 68%